Mizuho Securities USA LLC Has $22.45 Million Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Mizuho Securities USA LLC lifted its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 807.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,970 shares of the medical instruments supplier's stock after buying an additional 13,320 shares during the quarter. Mizuho Securities USA LLC owned approximately 0.07% of Mettler-Toledo International worth $22,451,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. PineStone Asset Management Inc. lifted its position in shares of Mettler-Toledo International by 127.4% in the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier's stock valued at $362,855,000 after acquiring an additional 145,453 shares in the last quarter. Capital International Investors lifted its holdings in Mettler-Toledo International by 15.1% in the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier's stock valued at $1,431,696,000 after purchasing an additional 141,431 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Mettler-Toledo International by 149,870.0% in the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier's stock valued at $134,946,000 after purchasing an additional 89,922 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Mettler-Toledo International by 88.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier's stock worth $163,290,000 after purchasing an additional 57,509 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its holdings in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier's stock worth $199,777,000 after buying an additional 35,048 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on MTD. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a report on Monday, November 11th. JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a "neutral" rating in a research note on Monday, August 5th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Finally, Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $1,338.75.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded down $58.20 during mid-day trading on Friday, hitting $1,179.58. The company's stock had a trading volume of 356,231 shares, compared to its average volume of 135,396. The firm's 50 day moving average is $1,382.02 and its 200 day moving average is $1,400.14. The company has a market cap of $24.89 billion, a PE ratio of 31.80, a price-to-earnings-growth ratio of 4.16 and a beta of 1.16. Mettler-Toledo International Inc. has a 52-week low of $1,041.49 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, analysts forecast that Mettler-Toledo International Inc. will post 40.37 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the business's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.